4183 Stock Overview
Manufactures and sells OEM/ODM blood glucose system in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
EPS Bio Technology Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$23.65 |
| 52 Week High | NT$30.60 |
| 52 Week Low | NT$19.55 |
| Beta | 0.59 |
| 1 Month Change | 2.60% |
| 3 Month Change | 0.64% |
| 1 Year Change | 4.65% |
| 3 Year Change | 31.39% |
| 5 Year Change | 20.66% |
| Change since IPO | 38.96% |
Recent News & Updates
Recent updates
Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)
Apr 16
Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?
Mar 20Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative
Feb 22Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?
Feb 01
Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?
Jan 04Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?
Dec 14We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential
Nov 23Shareholder Returns
| 4183 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 1.1% | 0.8% | 1.7% |
| 1Y | 4.6% | -5.9% | 28.0% |
Return vs Industry: 4183 exceeded the TW Medical Equipment industry which returned -5.9% over the past year.
Return vs Market: 4183 underperformed the TW Market which returned 28% over the past year.
Price Volatility
| 4183 volatility | |
|---|---|
| 4183 Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 4.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.9% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4183 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4183's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 116 | n/a | www.epsbio.com |
EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.
EPS Bio Technology Corp. Fundamentals Summary
| 4183 fundamental statistics | |
|---|---|
| Market cap | NT$562.87m |
| Earnings (TTM) | NT$30.30m |
| Revenue (TTM) | NT$485.02m |
18.6x
P/E Ratio1.2x
P/S RatioIs 4183 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4183 income statement (TTM) | |
|---|---|
| Revenue | NT$485.02m |
| Cost of Revenue | NT$355.03m |
| Gross Profit | NT$129.99m |
| Other Expenses | NT$99.69m |
| Earnings | NT$30.30m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.27 |
| Gross Margin | 26.80% |
| Net Profit Margin | 6.25% |
| Debt/Equity Ratio | 4.4% |
How did 4183 perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield63%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/26 06:29 |
| End of Day Share Price | 2025/01/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EPS Bio Technology Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pinghan Hsieh | Capital Securities Corporation |